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It is well established that an individual lymphocyte can be affected by more than 
one immunologic stimulus. Thus, the net response of  a lymphocyte may be determined 
by exogenous antigen, by major histocompatibility complex determinants present on 
the surface of antigen-presenting cells, and by positive and negative regulatory cells, 
and/or their products. Exposure to one or more of these stimuli can have functionally 
distinct consequences for the lymphocyte, including cell division, functional differ- 
entiation, paralysis, and cell death. Thus, it seems apparent that the lymphocyte must 
have a mechanism for distinguishing, integrating, and responding to multiple stimuli. 
One  possible  mechanism  for the  integration  of multiple  stimuli  by a  lymphocyte 
would be through interactions between different cell surface molecules. 
Two methods have been used to evaluate the existence of such interactions between 
lymphocyte surface molecules. In the first method, specific ligand (usually antibody) 
is bound to molecule A  and  the ability to serologically detect molecule B  is subse- 
quently evaluated. Using this method, interactions have been reported between Ia 
antigens and Fc IgG receptors (FcGR) 1 (1, 2) and LyM antigens and FcGR (3) on B 
lymphocytes, and between Ia antigens and FcGR (4, 5), H-2D  b and Lyt 2.2  (6,  7), 
H-2K  b and Lyt 1.2 (6, 7), H-Y and TL (8), D b and TL (6, 7), and H-Y and D b (8) on 
T  lymphocytes. The simplest (but not the only) interpretation of these data is that the 
interacting molecules are specifically  (nonrandomly)  located  in  close proximity to 
each other on the lymphocyte surface membrane.  Comparisons between fixed and 
unfixed  cells  have  shown  that  in  some  cases  the  interaction  existed  before  the 
introduction of the ligand, whereas in others it was induced by ligand (7, 8). 
In the second method, ligand is bound to molecule A and allowed to redistribute 
to one pole of the cell (capping). Cell surface molecule B is then evaluated for evidence 
of redistribution  paralleling  that  of molecule  A  (cocapping).  With  this  method, 
interactions  have  been  reported  between  surface  IgM  (sIgM)  and  FcGR  (9),  the 
l Abbreviations used in this paper: BSA, bovine serum albumin; BSA-PBS, Na phosphate-buffered  saline 
containing 2% BSA and 0.07% Na azide, pH 7.2; FcGR, Fc IgG receptor;  FITC, fluorescein  isothiocyanate; 
G, goat; H-aggregated IgG, FITC-conjugated  heat-aggregated  human Cohn fraction II IgG; HBSS-FCS, 
Hanks' balanced salt solution without phenol red containing 10% (vol/vol) heat-inactivated fetal calf 
serum; LPS, lipopolysaccharide;  R, rabbit; S, sheep; SDS-PAGE,  sodium dodecyl  sulfate-polyacrylamide 
gel electrophoresis; sIgD, surface IgD; sIgM, surface IgM; SPA-Sepharose, staphylococcal Protein A- 
Sepharose; TMRITC, tetramethylrhodamine  isothiocyanate;  TNP, trinitrophenyl. 
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lipopolysaccharide  (LPS)  receptor  and  slgM  (10),  and  surface  IgD  (slgD)  and  the 
LPS receptor (10) on B lymphocytes. The simplest  (but again, not the only) interpre- 
tation  of these  data  is  that  the  two  molecules  physically  interact  with  each  other 
directly or indirectly on the cell surface. 
The  purpose  of the  present  studies  was  to  further  characterize  the  interaction 
between two B  lymphocyte surface molecules, sIgM and FcGR. The results indicate 
that:  (a)  thee is a  specific interaction between slgM and FcGR on the B lymphocyte 
surface that requires occupancy of both receptors; and (b) occupancy of the FcGR by 
monomeric  IgG  produces  a  reversible  alteration  of this  receptor.  It  is  likely  that 
whenever slgM  is  involved in vivo in a  B  lymphocyte response to an  immunologic 
stimulus, the FcGR is also involved. 
Materials  and Methods 
Animals and Cells.  Adult male mice of strains C57BL/10Sn  (B10)  and B10.A/SgSn were 
purchased  from The Jackson Laboratory, Bar Harbor,  Maine.  Single cell  suspensions  from 
spleen were prepared by density flotation as previously described (1). The cells were resuspended 
at 20 ×  106/ml  in Hanks' balanced salt solution without phenol red containing 10% (vol/vol) 
heat-inactivated fetal calf serum (HBSS-FCS) for capping studies or in Na-phosphate-buffered 
saline  containing  2%  bovine serum  albumin  and  0.07%  Na azide,  pH  7.2,  (BSA-PBS)  for 
noncapping studies. 
Fluorescent Reagents 
FLUOROCHROME-CONJUGATED  F(ab')2  AND F(ab')  ANTI-Ig REAGENTS.  Rabbits and goats were 
immunized with purified myeloma proteins by standard  techniques.  The antisera  obtained 
were absorbed using solid-phase immunoabsorbents prepared by covalently coupling purified 
myeloma proteins or normal or newborn mouse serum to Sepharose or agarose via cyanogen 
bromide  (11).  The  IgG  fractions  of the  various  antisera  were  obtained  either  by affinity 
purification using solid-phase immunoabsorbents or DEAE cellulose chromatography. F(ab')2 
fragments were prepared by digestion of the IgG with pepsin (12), followed by chromatography 
on Sephadex G-150 to isolate the F(ab')2 fraction. Finally, these were absorbed with staphylo- 
coccal Protein A-Sepharose (SPA-Sepharose; Pharmacia Fine Chemicals, Div. of Pharmacia 
Inc., Piscataway, N. J.) to remove minor amounts of contaminating intact IgG. Certain of the 
F(ab')2 preparations were analyzed for contaminating IgG by sodium dodecyl sulfate-polyacryl- 
amide gel electrophoresis (SDS-PAGE). The F(ab')2 preparations were conjugated to fluorescein 
isothiocyanate (FITC;  13)  or tetramethylrhodamine  isothiocyanate (TMRITC) as described 
(14). The preparations were evaluated for specificity by the fluorescent staining of spleen cells, 
thymocytes, myelomas,  and  hybridomas  of known  Ig isotype,  as  well  as  Sepharose  beads 
coupled with various purified myeloma proteins. All reagents were specific inthat no inappro- 
priate fluorescence was observed. F(ab') fragments were prepared by reduction and alkylation 
(15) of the fluorochrome-conjugated F(ab')z preparations with subsequent isolation of  the F(ab') 
fraction by Sephadex G-150 chromatography. 
(a)  Rabbit F(ab')2 and F(ab') Anti-Mouse Mu [R-F(ab')~ and R-F(ab')  Anti-Mu].  Fluoro- 
chrome-conjugated R-F(ab'), anti-mu was prepared under contract NCI-CB-53912-31, except 
for the absorption with SPA-Sepharose, which was done in our laboratory. The immunogen 
was MC774 (IgMk) and the absorbents were MOPC141 (IgG2bk) and newborn mouse serum. 
The concentration used was 250 #g/ml. The preparation was 0.5% contaminated with intact 
IgG,  which  would  not  bind  to  SPA-Sepharose.  In  certain  experiments  (see Results)  the 
R-F(ab')z anti-mu was absorbed with R-anti-TNP-TNP-BSA-Sepharose. 
(b)  Goat F(ab')2 Anti-Mouse Mu [G-F(ab')z Anti-Mu].  Absorbed and affinity-purified goat 
IgG anti-mouse mu was a  kind  gift of Dr.  Richard  Asofsky, National  Institutes  of Health, 
Bethesda, Md. The immunogens were MOPC 104 (IgM~) and MC471B (IgMk). The absorbents 
were MOPC70A (IgGlk), MOPC173 (IgG2ak), and MOPC195 (IgG2bk). The antibodies were 
affinity-purified on TEPC183  (IgMk). The concentration used was  15-60 #g/ml.  It was 2% 
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(c)  Rabbit  F(ab')2  Anti-Mouse  Kappa  [R-F(ab')~  Anti-k].  Fluorochrome-conjugated 
R-F(ab')2 anti-kappa was prepared under contract NCI-CB-53912-31, except for absorption 
with SPA-Sepharose, which was done in our laboratory. The immunogen was PC5  (IgG2ak) 
and the absorbent was HOPC1  (IgG2a~). The concentration used was 200 #g/ml. 
(d)  Rabbit F(ab')2 and F(ab')  Anti-Mouse Delta [R-F(ab')2  and F(ab') Anti-Delta].  Fluoro- 
chrome-conjugated  F(ab')2 anti-delta was  given  and  prepared  (except  for  Sephadex g-150 
chromatography, which was done in our laboratory) by Dr. Fred D. Finkelman, Uniformed 
Services University of the Health Sciences, Bethesda, Md. The immunogen was TEPC1017 
(IgDk; 16) and the absorbents were normal mouse serum and TEPCI83 (IgMk). It was affinity- 
purified with TEPC1033  (IgDk;  16) and was used at a concentration of 20 #g/ml for F(ab')2 
and 150 #g/ml for F(ab'). 
(e)  Rabbit F(ab')z  Anti-Mouse IgG2 [R-F(ab')2  Anti-lgG2].  Fluorochrome-conjugated R- 
F(ab')2 anti-IgG2 was prepared under contract NCI-CB-53912-31  except for absorption with 
SPA-Sepharose, which was done in our laboratory. The immunogen was PC5 (IgG2ak) and the 
absorbents were MOPC21  (IgGlk) and MC774 (IgMk). It was used in conjunction with anti- 
I-A antibody (see below). 
Igo ^NTI-MOtJSE xg.  Rabbit IgG anti-mouse Ig conjugated with FITC (R-IgG anti-Ig) was 
purchased from N. L. Cappel Laboratories, Inc., Cochranville, Pa. (lot 7282).  It was ultracen- 
trifuged before use (17) and was used at a dilution of 1:8. 
ANTH-^ ^wrmovv.  IgG2b  anti-I-A  k was  purified by affinity chromatography on  SPA- 
Sepharose from tissue culture supernatant fluids of hybridoma 10-2.16  (18; obtained from The 
Salk Institute, San Diego, Calif.). For the present experiments, it was necessary to prevent this 
antibody from binding to FcGR via the Fc portion of the molecule. It was found in preliminary 
experiments that preincubation for 30 min at 4°C with sufficient (> 17/1, wt/wt) fluorochrome- 
conjugated R-F(ab')2 anti-IgG2 would prevent binding of IgG2a (HOPC1)  to the FcGR on 
P388Dt cells (David M. Segal and Howard B. Dickler, unpublished observations). Therefore, 
equal volumes of 10-2.16  (4.5 pg/ml)  and fluorochrome-conjugated RF(ab')2 anti-IgG2 (125 
pg/ml) were preincubated for 30 min at 4°C for use in the experiments. The R-F(ab')2 anti- 
IgG2 also provided labeling for fluorescent detection of I-A  k, and  sufficient cross-linking to 
produce capping (see Results). 
Igo COMPLEXES.  Two types of complexes were utilized for detection of FcGR on B lympho- 
cytes. 
(a)  Antigen-Antibody Complexes.  The  methodology for preparation of the soluble antigen- 
antibody complexes and their cross-linking  and indirect fluorescent detection has been described 
in  detail  (19).  Briefly, affinity-purified rabbit  anti-trinitropbenyl (R-anti-TNP)  and  TNP- 
conjugated bovine serum albumin (TNP-BSA) were mixed at fourfold antigen excess to produce 
soluble complexes that were used at 10 #g/ml (antibody). Further cross-linking and fluorescent 
detection were obtained with FITC- or TMRITC-labeled affinity-purified sheep (S)-anti-TNP 
or R-anti-TNP (125-250 pg/ml). The affinity-purified anti-TNP antibodies were the kind gift 
of Dr. Pierre Henkart, National Institutes of Health, Bethesda, Md. 
(b)  Heat-aggregated IgG.  FITC-conjugated, heat-aggregated human  Cohn  fraction II IgG 
(H-aggregated IgG) was prepared as previously described (1) and used at 2 mg/ml. 
MONOMERm MOUSE Igo.  Mouse IgG was purchased from Miles Laboratories, Elkhart, Ind. 
This IgG was chromatographed on Sephadex G-150 and the second half of the 7S peak was 
isolated, concentrated, and ultracentrifuged immediately before use to remove material _>10S 
(17).  The concentration used was 5 mg/mi. In certain experiments (see Results), the IgG was 
absorbed with FITC-R-IgG-Sepharose. 
Fluorescence.  Cells (5  ×  105 in 25 pl) and reagent  (100 pl for R-anti-TNP-TNP-BSA and 
mouse IgG, 25 #1 for all others) were incubated for 30 min at 4°C and then washed thoroughly 
with  4°C  medium.  In  protocols involving more  than  one  reagent,  the  reagents were  used 
sequentially in the order noted in Results with thorough washing between each reagent. BSA- 
PBS  (which contained Na azide) was the medium used in protocols not requiring capping, 
whereas in those that required capping, HBSS-FCS was used until capping was ended with 
BSA-PBS. Cells were kept at 4°C throughout, except during capping. Capping was induced by 
resuspen~ling the cells in 1 ml of HBSS-FCS and incubating at 37°C for 15-20 min. Wet mount 
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microscopy as previously described (20). A minimum of 200 small lymphocytes per preparation 
were evaluated. The criterion for fluorescence positivity for each of the molecules evaluated was 
punctate staining over the entire surface of the cell (except when  using monomeric F(ab') 
antibodies where the pattern was a smooth ring). The fluorescence was considered capped when 
it was concentrated on < 1/2 of the cell surface at one pole of the cell. 
Results 
Lack  of Interaction  between slgM and  FcGR  if Only  One  of the  Receptors  Is  Ligand- 
occupied.  B  lymphocyte sIgM and FcGR were evaluated for interactions by binding 
ligand to one of the two receptors. The cells were subjected to capping or noncapping 
conditions,  followed  by  immunofluoreseent  evaluation  of the  second  receptor  for 
detectability and distribution. Fluorochrome-labeled F(ab')2 fragments of rabbit IgG 
specific  for  mouse  mu  [R-F(ab')2  anti-mu]  were  used  for  sIgM.  Soluble  antigen- 
antibody complexes composed of TNP-BSA and rabbit IgG specific for TNP  (R-anti- 
TNP-TNP-BSA),  followed by fluorochrome-labeled sheep  IgG specific for TNP  (S- 
anti-TNP,  used  for both  detection  and  further  cross-linking)  were  used  for  FcGR 
(Table I). The percentage of spleen cells positive for FcGR and  the distribution of 
FcGR on those cells were unaffected by binding of ligand to sIgM or ligand-induced 
redistribution of sIgM  (parts  5  and  6  vs.  part  1).  Similarly, the percentage of cells 
positive  for  sIgM  and  the  distribution  of  sIgM  were  unaffected  by  binding  of 
TAaLE  I 
Lack of Interaction between B Lymphocyte slgM and FcGR under Capping and Noneapping Conditons 
When Only One of the Receptors Is Ligand-Occupied 
Part 
Incubation*  sIgM  FcGR 
1  2  3  Positive  Capped~  Positive  Capped 
%  % 
1  R-anti-  S-anti-  --  61.5  4 
TNP-  TNP§ 
TNP-BSA 
2  R-F(ab')2§  --  --  55.0  2 
anti-ran 
3  R-anti-  S-anti-TNP  R-F(ab')2  54.0  6  61.0  5 
TNP-  anti-mu 
TNP-BSA 
4  R-anti-  S-anti-TNP  ~-~  R-F(ab')2  56.0  5  60.0  77 
TNP-  anti-mu 
TNP-BSA 
5  R-F(ab')2  R-anti-  S-anti-TNP  52.0  2  58.5  3 
anti-mu  TNP- 
TNP-BSA 
6  R-F(ab')2  ~  R-anti-  S-anti-TNP  56.0  89  58.5  4 
anti-mu  TNP- 
TNP-BSA 
* All incubations were at 4°C for 30 rain, and cells were washed thoroughly with iced medium between 
each incubation.  The arrow means that between the indicated incubations  the cells were subjected  to 
capping conditions  (37°C for 15-20 rain in HBSS-FCS). This same medium  was used for incubations 
and washes before capping conditions, whereas BSA-PBS was used for incubations  and washes after 
capping conditions and throughout  parts without capping conditions. 
Percentage of positive cells with fluorescence visible on ~ 1/2 of the cell surface at one pole of the cell. 
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complexes  to FcGR or ligand-induced capping of FcGR (parts 3 and 4 vs. part 2). 
These results, with one exception, are consistent with the observations of a number of 
laboratories  (reviewed  in  reference  21)  and  indicate  that  the  two  receptors  are 
independent molecules that are not in close enough proximity on the cell membrane 
for steric  inhibition of detection to occur.  However, the result obtained in part  6 
differs  from that reported by Forni and Pernis  (9), who observed that capping of 
sIgM with F(ab')2 anti-mu resulted in redistribution (cocapping)  of FcGR, and from 
the result of Abbas and Unanue (22), who found cocapping of FcGR after capping 
with F(ab')2 anti-kappa. 
To resolve this discrepancy, sIgM was capped with several different anti-Ig reagents 
and FcGR were evaluated with two types of complexes (Table II). Capping of sIgM 
with F(ab')2  fragments of two different anti-mu antibody preparations (one rabbit 
and one goat)  and of an anti-kappa antibody preparation (which would also bind to 
sIgD)  failed to induce redistribution of FcGR  (experiment A,  parts  1,  2,  and 4). 
Moreover, evaluation of FcGR with different complexes  (heat-aggregated IgG)  also 
failed to reveal any cocapping (experiment A, part 3). In contrast, capping with intact 
rabbit IgG anti-mouse Ig both inhibited FeGR detection and induced FcGR redistri- 
bution  (experiment  A,  part  5),  presumably due  to  the  Fc portion of the anti-Ig 
antibodies binding direct to FcGR. In addition, capping with F(ab')2  fragments of 
anti-mu IgG purified after pepsin digestion by chromatography on Sephadex G-150 
but not absorbed with staphylococcal Protein A to remove residual contaminating 
intact IgG (a procedure not available when the earlier studies [9, 22] were done) also 
induced some FcGR redistribution (experiment B, part 2). This latter result suggests 
the possibility that the earlier results  (9, 22) were due to small amounts of intact IgG 
contaminating the F(ab')2  preparations used.  Alternatively, it was conceivable that 
Protein A had leaked from the Protein A-Sepharose,  was present in the F(ab')2 anti- 
TABLE II 
Effect of Redistributing B Lymphocyte slgM with Various Anti-Ig Reagents on FcGR 
Experiment  Part 
Incubation*  slgM:~  FcGR 
l  2  3  Positive  Capped§  Positive  Capped 
%  % 
A  l  R-F(ab')2  ~  R-anti-TNP-  S-anti-TNP  52.0  88  64.0  9 
anti-mu  TNP-BSA 
2  C,-F(ab')2  ~,  R-anti-TNP-  S-anti-TNP  54.0  91  59.0  8 
anti-mu  TNP-BSA 
3  G-F(ab%  ~  H-aggregated  --  56.0  84  66.0  6 
anti-mu  IgG 
4  R-F(ab%  ~  R-anti-TNP-  S-anti-TNP  51.5  76  60.0  7 
anti-kappa  TNP-BSA 
5  R-IgG anti-lg  ~  R-anti-TNP-  S-anti-TNP  58.0  83  22.0  91 
TNP-BSA 
B  1  R-F(ab')2  *-*  R-anti-TNP-  S-anti-TNP  66.0  82  62.5  4 
anti-mu  TNP-BSA 
2  R-F(ab')~  ~.  R-ami-TNP-  S-anti-TNP  60.5  86  62,0  23 
anti-mu  TNP-BSA 
3  R-anti-TNP-  S-anti-TNP  ~,  --  64.0  91 
TNP-BSA 
* See footnote to Table L R-F(ab% anti-mu, R-F(ab')2 anti-kappa, R-IgG anti-Ig, H-aggregated IgG, and S-anfi-TNP (experiment A, part 2) 
were labeled with FITC. G-F(ab')2 anti-mu and S-anti-TNP (experiment A, parts 1, 4, and 5, and experiment B) were labeled with TMRITC. 
:~ Anti-kappa and anti-Ig would also bind to slgD. 
§ See footnote to Table L 
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mu, and in some fashion artifactually obviated the sIgM-FcGR interaction. However, 
this possibility  was  quite unlikely for several  reasons:  (a)  the SPA-Sepharose was 
always washed with 6 M guanidine to remove any protein not covalently coupled to 
the Sepharose before equilibration with the filtration buffer (PBS);  (b)  no protein 
(<3 #g/ml) was detected in the PBS, which passed through the SPA-Sepharose;  and 
(c) SDS-PAGE of the R-F(ab')2 anti-mu for contaminants failed to show any protein 
in the molecular weight range of SPA (42,000) or SPA-IgG complexes even with the 
gels overloaded (see Materials and Methods). Thus, it was concluded that sIgM and 
FcGR did not interact if only one of the receptors  was occupied by ligand. It was 
therefore of interest to determine whether the two receptors  would interact if they 
were simultaneously occupied by their respective  ligands. 
Redistribution of B Lymphocyte slgM Induces Redistribution of FcGR Independently Occupied 
by IgG.  The experimental approach was to occupy both sIgM [with R-F(ab')2 anti- 
mu] and FcGR (with antigen-antibody complexes,  R-anti-TNP-TNP-BSA) simulta- 
neously, subject the ceils to capping conditions, and determine whether capping of 
sIgM affected the distribution of occupied FcGR (Table III). For this approach to be 
informative, it is necessary that the antigen-antibody  complexes themselves not induce 
capping of FcGR within the time period analyzed. As previously documented (23), 
the soluble complexes used in this study induced capping of FcGR on only a minority 
of the B lymphocytes (experiment A, part 2). This is presumably a reflection of the 
degree of cross-linking  obtained, because if further cross-linking  is produced with R- 
anti-TNP before capping, FcGR capped to approximately the same degree as ligand 
cross-linked  sIgM (experiment A, part  1 vs. 3).  When cells were analysed that had 
both sIgM and FcGR occupied and had been subjected to capping conditions, it was 
observed  that  the  FeGR  had  capped  nearly as  well  as  when  highly cross-linked 
(experiment A, part 4). Because neither capping of sIgM alone (part 1) nor the soluble 
TABLE III 
Redistribution of B Lymphocyte slgM Induces Redistribution of FcGR Occupied by Antigen-Antibody 
Complexes 
Experiment  Part 
Incubation*  slgM  FcGR 
1  2  3  Positive  Capped$  Positive  Capped 
%  % 
A  1  R-F(ab')2  ~.  R-anti-TNP-  R-anti-TNP  63.0  76  62.0  3 
anti-mu  TNP-BSA 
2  R-anti-TNP-  ~  R-anti-TNP  --  61.0  20 
TNP-BSA 
3  R-artti-TNP-  R-anti-TNP  ,,--,  --  65.5  72 
TNP-BSA 
4  R-F(ab%  R-anti-TNP-  ,,-*  R-anti-TNP  64.0  78  64.0  63 
anti-mu  TNP-BSA 
B§  1  R-F(ab')a  ~  R-anti-TNP-  R-anti-TNP  60.0  73  63..5  2 
anti-mu  TNP-BSA 
2  R-anti-TNP-  ~  R-anti-TNP  --  60.0  18 
TNP-BSA 
3  R-anti-TNP-  R-anti-TNP  ~  --  60.5  69 
TNP-BSA 
4,  R-F(ab~)~  R-anti-TNP-  ~  R-anti-TNP  60.0  80  60.0  62 
anti-mu  TNP-BSA 
* See footnote to Table I. R-F(ab% anti-mu was labeled with FITC and R-anti-TNP was labeled with TMRITC. 
:1: See footnote $, Table I. 
§ In experiment  B, R-F(ab')2 antl-mu was pre-absorbed  with R-anti-TNP-TNP-BSA-Sepharosc,  and R-anti-TNP  (in the complex) was pre- 
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complexes alone  (part  2)  produced this capping, this result  suggested an interaction 
between sIgM and FcGR when both were occupied. One artifact that could also have 
produced this result  was a  cross-reaction between  the ligands  themselves. Although 
the  protocols  for preparation  of these  ligands  (see  Materials  and  Methods)  should 
have precluded such cross-reactions, the R-F(ab')2 anti-mu was absorbed with insol- 
ubilized  complexes,  the  R-anti-TNP  used  in  the  complexes  was  absorbed  with 
insolubilized  rabbit  IgG conjugated  with  FITC,  and  the  experiment  was repeated 
(experiment  B). The results were identical,  making it very unlikely that ligand cross- 
reactions were the explanation.  In a series of 12 independent experiments, 86% of the 
B  lymphocytes  whose  sIgM  was  redistributed  into  a  cap  also  had  capped  FcGR, 
provided the latter were occupied at the time by complexes. The same result was also 
obtained with spleen cells from other strains including C3H/HeJ,  A/J, and CBA/N 
(data not shown). It was concluded that sIgM and FcGR interact if both are ligand- 
occupied. 
Because FcGR are constantly exposed in vivo to monomeric IgG, it was of interest 
to determine  whether  FcGR occupied by monomeric IgG would  also  interact  with 
sIgM. The experimental  approach was similar  to that  used for complexes with two 
modifications  necessitated  by  the  low  binding  avidity  of  monomeric  IgG  to  B 
lymphocyte FcGR.  First,  the  monomeric IgG was continuously  present  during  the 
capping period, and second, the distribution  of FcGR was subsequently detected by 
labeling  with  complexes  and  fluorochrome-labeled  R-anti-TNP  (Table  IV).  When 
cells  labeled  with  R-F(ab')2  anti-mu  were  subjected  to  capping  conditions  in  the 
continuous  presence  of monomeric  IgG and  then  analyzed  for  the  distribution  of 
FcGR,  it  was observed  that  approximately  half of the  B  lymphocytes had  all  their 
TABLE  IV 
Redistribution of B Lymphocyte slgM Induces Redistribution of FcGR Occupied by Monomeric IgG 
Part 
Incubation*  FcGR 
1  2  3  4  Positive  Capped:~ 
% 
1  R-F(ab')2  ~  R-anti-TNP-  R-anti-TNP  --  54.0  11 
anti-mu  TNP-BSA 
2  R-F(ab')2  R-anti-TNP-  ~  R-anti-TNP  --  54.0  81 
anti-mu  TNP-BSA 
3  R-F(ab')2  R-anti-TNP-  ~  R-anti-TNP-  R-anti-TNP  60.0  47 
anti-mu  TNP-BSA  TNP-BSA 
4  R-F(ab')z  Mouse IgG§  ~  R-anti-TNP-  R-anti-TNP  56.0  46 
anti-mu  TNP-BSA 
5  R-F(ab')2  Mouse IgG§  ~  R-anti-TNP-  R-anti-TNP  54.0  15 
anti-mu  TNP-BSA 
6  Mouse IgG§  ~  R-anti-TNP-  R-anti-TNP  --  55.0  11 
TNP-BSA 
* See footnote to Table I. R-F(ab')z anti-mu was labeled with FITC and R-anti-TNP  was labeled with 
TMRITC. 
:I: See footnote to Table I; sIgM was 53.0% positive and 75% capped. 
§ Mouse IgG was pre-absorbed with FITC-R-IgG-Sepharose, ehromatographed on Sephadex G-150, and 
ultracentrifuged  immediately before use (see Materials and Methods). In parts 4 and 6, the IgG was 
present during capping conditions at a final concentration of 0.5 mg/ml. In part 5, the IgG was washed 
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FcGR redistributed into a cap (part 4). Neither capping of sIgM alone (part  1)  nor 
monomeric IgG alone (part 6)  induced this redistribution. The fact that FcGR were 
redistributed into a cap on only half the B lymphocytes is more apparent than real. 
First, because of the subjective nature of the assay, only cells in which all FcGR are 
at  one  pole of the  cell  are  counted  as  capped.  In  fact,  although  many  of the  B 
lymphocytes in part 4 had most of their FcGR in a cap, some were elsewhere on the 
cell surface and so were counted as noncapped. Second, previous studies have shown 
that after capping of FeGR directly by highly cross-linked complexes, reexposure to 
complexes shows some FcGR outside the cap (24, 25). It is thought that this is due to 
rapid  reexpression  of FcGR.  A  similar  phenomenon was  apparent  in  the  present 
experiments. Thus,  FcGR occupied by soluble complexes during capping of sIgM 
were found capped on 81% of the positive cells (part 2).  However, if the cells were 
reincubated with complexes after capping, all the FcGR were in the cap on only 47% 
of the cells (part 3), a result equivalent to that obtained with monomeric IgG. It was 
concluded  that  occupancy  of FcGR  by  monomeric  IgG  is  sufficient  to  lead  to 
interaction  with  sIgM  on  the  majority  of B  lymphocytes, although  for  technical 
reasons this can only be directly demonstrated on half of the B cells. 
Several other points  are worth noting.  Cross-reactions between the ligands were 
excluded by absorptions (see Materials and Methods and Table IV, footnote §). Also, 
every effort was made to insure that the IgG was monomeric i.e., Sephadex G-150 
chromatography was planned so that  the material obtained (second half of the  7S 
peak) was not stored before use and was ultracentrifuged to remove dimers or larger 
immediately before use. In addition, fresh normal mouse serum produced a  similar 
result (data not shown). The concentration of  IgG required (0.5 mg/ml) is considerably 
less than is present in serum and titration experiments indicated that as little as 0.01 
mg/ml produced some effect (data not shown). Finally, the effect of the monomeric 
IgG on FcGR is completely reversible because if it is washed away immediately before 
capping, redistribution of FcGR does not occur (part 5). 
Lack of Interaction between Immune Complex-occupied  FcGR and sIgM Occupied by Monomeric 
Anti-Mu.  To further characterize the interaction between sIgM and FcGR, we asked 
whether the capping of FcGR by highly cross-linked complexes would induce redis- 
tribution  of sIgM  occupied by monomeric anti-mu  (Table V).  Lymphocytes were 
TABLE g 
Redistribution of B Lymphocyte FcGR Does Not Induce Redistribution of sIgM Occupied by Monomeric 
F(ab  ') Anti-Mu 
Part 
Incubation"  slgM  FcC,  R 
!  2  3  Positive  Capped:~  Positive  Capped 
%  % 
1  R-F(ab')  anti-  ~  --  --  55.0  4 
mu 
2  R-F(ab')2  ~  --  --  54.5  85 
anti-mu 
3  R-anti-TNP-  R-ami-TNP  ~  --  57.0  89 
TNP-BSA 
4  R-anti-TNP-  R-anti-TNP  R-F(ab')  anti-  *-*  54.0  4  53.0  92 
TNP-BSA  mu 
* See footnote to Table  I. R-F(ab ~) anti-mu and R-F(ab%  anti-too were labeled with FITC  and RLanti-TNP was labeled with TMRITC. 
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allowed to bind soluble R-anti-TNP-TNP-BSA complexes, which were then further 
cross-linked by additional  R-anti-TNP.  The  sIgM was then  labeled  with  R-F(ab') 
anti-mu  and the cells were subjected  to capping conditions  (part 4).  Although  the 
FcGR were capped on 92% of the positive cells, no redistribution of sIgM occurred. 
The  control  (part  2)  indicated  that  sIgM  would  cap  normally  if cross-linked by 
divalent F(ab)z anti-mu (from which the monomer was prepared by reduction  and 
alkylation).  This  result  conflicts  with  that  reported  by  Unanue  and  Abbas  (26). 
However, it was later found that the latter result was due to a cross-reaction between 
ligands (E. R. Unanue, personal communication). Thus, an interaction between sIgM 
and FcGR could not be demonstrated if sIgM was occupied by monomeric ligand. 
The simplest explanation would be that sIgM must be cross-linked in order to interact 
with FcGR. Because cross-linked sIgM caps very rapidly, this possibility could not be 
directly investigated with the present experimental approach. 
Specificity of the Interaction between sIgM and FcGR.  It was of interest  to determine 
whether  interactions  would  occur  between  any  two  ligand-occupied  cell  surface 
molecules  on  B  lymphocytes,  as  opposed  to  the  possibility  that  the  sIgM-FcGR 
interaction was unique. Ligand-induced capping ofsIgM failed to elicit redistribution 
of sIgD occupied by monomeric anti-delta (Table VI, part 5). Moreover, no evidence 
of any interaction between sIgM and sIgD was obtained. Thus, binding of ligand to 
one  of these  molecules  did  not  inhibit  detection  of the  second  molecule,  nor  did 
capping of one of the  molecules  induce  redistribution  of the  other,  irrespective of 
whether the second was ligand-occupied  (Table VI). Capping of sIgM also did not 
induce significant redistribution  of antibody-bound I-A antigens  (Table VII, part 5 
vs. part 2). It is worth noting that the antibody for I-A was at least divalent. This was 
possible because even when highly cross-linked, this molecule capped slowly. It would, 
however, cap on the majority of B cells, given sufficient time (part 3). Thus, capping 
of sIgM  induced  redistribution  of ligand-oceupied  FeGR  but  not  ligand-occupied 
sIgD or I-A antigens. 
Experiments  were  also  carried  out  to  determine  whether  capping of another  B 
lymphocyte surface molecule (sIgD) would induce redistribution of ligand-occupied 
FeGR. It was found that capping of sIgD induced redistribution  of ligand-occupied 
FcGR but  the interaction  was distinct  from that  with sIgM in that  (a)  it occurred 
TABLE  VI 
Lack ofInt~actwnBetweenBLympho~u slgMandslgD 
Part 
Incub~ion* 
1  2 
slgM  slgD 
Positive Capped~  Positive  Capped 
%  % 
1  G-F(ab')2  anti-mu  R-F(ab')2 anti-delta  50.0  4  47.0  4 
2  R-F(ab')2  anti-delta  G-F(ab')z  anti-mu  48.0  3  49.5  2 
3  G-F(ab')2  anti-mu  ~  R-F(ab')2  anti-delta  50.0  84  49.4  5 
4  R-F(ab')2  anti-delta  ~  G-F(ab')~  anti-rnu  49.0  5  51.0  87 
5  G-F(ab')a  anti-mu  R-F(ab') anti-delta  ~  51.0  84  49.0  7 
6  R-F(ab')2  anti-delta  R-F(ab') anti-mu  ~  51.0  6  50.0  87 
* See footnote to Table I. O-F(ab')2  anti-mu and R-F(ab')2  anti-delta (part 6) were labeled with TMRITC. 
R-F(ab')2 anti-delta, R-F(ab') anti-delta, and R-F(ab') anti-mu were labeled with FITC. 
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TABLE VII 
Redistribution of B Lymphocyte slgM Does Not Induce Redistribution of Antibody-bound I-A Antigens 
Part 
Incubation*  sIgM  I-A  k 
1  2  Positive  Capped:]:  Positive  Capped 
%  % 
1  Anti-I-A  --  54.0  0 
2  Anti-I-A  ~-~  --  54.0  7 
3  Anti-I-A§  ~  --  55.0  69 
4  G-F(ab')2 anti-mu  ~  Anti-I-A  51.0  82  54.0  0 
5  G-F(ab')z anti-mu  Anti-I-A  ~  52.0  78  53.0  12 
* See footnote to Table I. Spleen cells were B10.A.  Anti-I-A -- IgG2 anti-I-A  k (10-2.16)  preincubated with 
27  times  (wt/wt) of R-F(ab')2 anti-lgG2  labeled  with FITC.  The  latter  reagent  prevents the  anti-Ia 
antibody from binding to FcGR (see Materials and Methods) in addition to producing cross-linking and 
labeling. G-F(ab')2 anti-mu was labeled with TMRITC. 
:~ See footnote to Table I. 
§ The capping conditions in part 3 were maintained for 120 min. 
only with immune complexes and not with monomeric IgG; and (b) it occurred only 
on a  subpopulation  of B  lymphocytes. These results were unexpected and will be 
reported  in  detail separately  (H.  B.  Dickler and  F.  D.  Finkelman, manuscript  in 
preparation). It was concluded that the slgM-FcGR interaction was specific. 
Discussion 
The experimental results presented indicate an interaction between two independ- 
ent B lymphocyte surface membrane receptors, the IgM receptor for antigen, and the 
receptor specific for the Fc portion of IgG. This interaction required simultaneous 
occupancy of both receptors by independent ligands. Monomeric ligand (IgG) bound 
to FcGR induced interaction, whereas divalent ligand was required for slgM. The 
interaction was specific in that it did not occur between other pairs of ligand-occupied 
B cell surface molecules, e.g., slgM-slgD and slgM-I-A antigen. Although the inter- 
action was demonstrated via the phenomenon of cocapping, the results in no way 
suggest, nor do we believe, that capping itself is important in B cell differentiation or 
function. Two major questions raised by these results are (a) what is the nature of the 
slgM-FcGR interaction? and (b) what is its physiologic significance? 
It  is  likely that  slgM  and  FcGR  interact  physically, directly or  indirectly. The 
strongest evidence for this conclusion comes from the observation that FcGR occupied 
by monomeric IgG can be induced to cap by simultaneously capping slgM. This is, 
to our knowledge, the first example of a membrane molecule capping when occupied 
by  ligand  that  is  itself unable  to  produce  capping.  Because  the  capping  process 
depends on cross-linking in a  variety of systems (reviewed in reference 27),  it seems 
likely that  the ligand-occupied slgM  is inducing cross-linking of the IgG-occupied 
FcGR. This could take place via a direct slgM-FcGR binding or could be mediated 
by an intermediate molecule. Although the present experiments do not exclude an 
intermediate, we favor a direct binding between slgM and FcGR because this would 
be more economical and because of the apparent specificity of the interaction. The 
binding of ligand-occupied slgM  to  ligand-occupied  FcGR would  presumably  be 
noncovalent  because  the  interaction  induced  by  monomeric  IgG  was  completely 
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that the binding of ligands alters these receptors, leading to the exposure of binding 
sites.  Such alterations could be conformational or due to exposure of sites previously 
not available, e.g., hidden in the membrane. At present, there is no evidence to favor 
either of these possibilities. Our view of the interaction between sIgM and FcGR is 
presented schematieaUy in Fig.  1. 
In  view  of the  fact  that  the  sIgM-FcGR  interaction  occurs  in  the  presence of 
monomeric IgG at  concentrations present  in  vivo, it  appears  likely that  whenever 
sIgM is involved in a B lymphocyte response via interaction with antigen, the FeGR 
would  also be  involved. Based  on evidence that  the  ligand  anti-mu  antibody can 
induce proliferation orb lymphocytes (28, 29), i.e., signal the B cell, this suggests that 
the sIgM-FeGR interaction is important in signaling the B  lymphocyte. We would 
like to propose that this interaction can provide either positive or negative signals to 
the B cell, depending on the nature of the ligand occupying the FcGR. 
In terms of a negative signal to the B lymphocyte, there is a substantial amount of 
evidence implicating  the  FcGR. It  has been known  for several years that  antigen- 
antibody complexes can inhibit the antibody response in an antigen-specific manner, 
and that this inhibition requires an intact Fc portion of the antibody (30). However, 
because such  antibody responses require several  collaborating cell  types,  many of 
which bear FcGR, it has been difficult to demonstrate that this effect was mediated 
by the FeGR of the B lymphocyte (31).  In contrast, other model systems have more 
Y  Y 
' -"--Unoccupied  FcGR-----"" 
+  Monomeric  IgG "1" 
+  Anti-/~  /x 
Fro.  1.  Hypothetical model for direct interaction between B lymphocyte slgM and FcGR when 
both are occupied by their respective ligands. The surface membrane, for simplicity, is shown as a 
single line that represents the external side of the lipid bilayer. The major portions of both sIgM 
and FeGR that are not exposed are presumed to be within the lipid bilayer. After binding of their 
respective ligands, both FcGR  (ligand  =  IgG)  and slgM  (model ligand =  anti-mu)  expose sites 
previously bidden in the lipid bilayer. These sites then interact directly. Although this interaction 
is shown diagrammatically as a solid line, the evidence suggests that this interaction is noncova|ent 
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directly implicated the FcGR of B lymphocytes in negative signaling. Both LPS and 
anti-mu antibody-induced proliferation of B lymphocytes can be inhibited by anti- 
bodies bound to the B cell surface and this inhibition requires an intact Fc portion of 
the antibody (32,  33).  slgM has also been implicated in negative signaling. Under 
circumstances in which slgM is the predominant Ig isotype (neonatal B cells or B cells 
from the CBA/N strain) or the exclusive isotype (due to removal of slgD by enzymes 
or modulation with anti-delta antibodies)  on  the majority of B  lymphocytes, then 
tolerance induction (a type of negative signal) is greatly facilitated (34-36). Thus, the 
available evidence is consistent with the possibility that the sIgM-FcGR interaction 
would provide a negative signal to the B lymphocyte when the FcGR is occupied by 
antibody. 
In terms of positive signaling, two groups of workers have proposed (37, 38), on the 
basis of indirect evidence, that  the FcGR is  the site of binding for T  lymphocyte 
helper factor. Moreover, it has recently been demonstrated that B lymphocytes in the 
presence  of F(ab')2  anti-mu  and  T  cell  helper  factor  will  both  proliferate  and 
differentiate into antibody-forming cells (39). Thus, it seems possible that the slgM- 
FcGR interaction could provide a  positive signal to the B lymphocyte if the FcGR 
was occupied by T  cell helper factor. 
The proposal that the interaction of slgM and FcGR can provide both positive and 
negative signals to the B cell depending on the nature of the ligand bound to the 
FcGR requires two further elements. First, how does the FcGR know which ligand to 
bind?  The  simplest  mechanism  would  be  competition  for  the  receptor  based  on 
relative affinities of the ligands, and the order (a)  monomeric IgG, then  (b)  T  cell 
helper factor, then (c) complexed IgG would seem the most reasonable. Second, how 
does the cell  know which ligand  is bound  to  the  FcGR? Two  mechanisms could 
accomplish this.  Either IgG and T  cell helper factor bind to different sites on the 
FcGR (in which case the competition mentioned above would be steric), or the cell 
possesses  a  recognition mechanism that distinguishes FcGR-IgG from FcGR-T cell 
helper factor. No evidence is available to distinguish these possibilities. 
The hypotheses put forward above appear to be testable with available experimen- 
tal techniques. It will also be of interest to examine other cell surface molecules for 
interactions and determine whether such interactions have general importance in cell 
signaling. 
Summary 
The  independent  B  lymphocyte surface  membrane  receptors  IgM  and  Fc  IgG 
receptors were evaluated for interactions using immunoflourescence. Ligand [F(ab')2 
anti-mu]-induced capping of surface IgM resulted in capping of Fc IgG receptors 
only if the latter were occupied during the capping process by:  (a) soluble antigen- 
antibody complexes that  themselves provided insufficient cross-linking to result  in 
capping; or (b) monomeric IgG at physiologic concentrations (or less) either purified 
or as normal serum. Ligand-induced capping of Fc IgG receptors did not result in 
capping of surface IgM occupied by monomeric F(ab') anti-mu. Control experiments 
showed that ligand binding to or capping of only one of these two receptors has no 
effect on the other, and that there were no cross-reactions. The interaction appears 
specific in  that  ligand-induced capping of surface IgM did not induce capping of 
ligand-occupied surface IgD or I-A  antigens.  Thus,  there  appears  to be  a  specific HOWARD B.  DICKLER AND MARY T.  KUBICIEK  1341 
interaction between ligand-bound surface IgM and ligand-bound Fc IgG receptors on 
the B lymphocyte surface. The results also indicate that binding of monomeric IgG 
produces a  reversible  alteration  in  the  Fc IgG receptor leading to association with 
ligand-bound surface  IgM.  Because  Fc IgG receptors  are  continuously exposed  to 
monomeric IgG in vivo, these results suggest that whenever surface IgM is involved 
in a  B lymphocyte response to an immunologic stimulus, the Fc IgG receptor is also 
involved. 
Received  for publication 1 December 1980 and in revised  forra 9 February 1981. 
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